Physician profile
David Essig
NPI 1154588341
$123,142.21
in general payments reported to CMS, 2019-2025
12 companies · $39K in 2025
The $39K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,238 · 2020: $275 · 2021: $357 · 2022: $35K · 2023: $15K · 2024: $30K · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $76K · Travel and Lodging: $5,046 · Food and Beverage: $2,618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $76,075.00 |
| Travel and Lodging | $5,046.07 |
| Food and Beverage | $2,618.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $62,973.46 | 2022-2025 | Everest Spinal System, Mesa Spinal System, Cascadia Interbody System |
| Vb Spine LLC | $38,519.40 | 2025 | Everest Spinal System, Napa Access System, Yukon Oct Spinal System |
| Si-Bone, INC. | $10,954.55 | 2021-2024 | |
| Depuy Synthes Products, INC. | $4,361.86 | 2024 | Mountaineer, Symphony |
| Medtronic USA, INC. | $3,950.89 | 2019 | |
| Medical Device Business Services, INC. | $1,347.74 | 2024 | Mountaineer, Symphony, Skyline |
| Medicrea USA, Corp. | $562.79 | 2019-2020 | |
| Prosidyan, INC | $178.60 | 2021 | |
| Orthofix Medical, INC. | $135.22 | 2024 | Spinal-Stim |
| Medtronic, INC. | $132.14 | 2021 | |
| Depuy Synthes Sales INC. | $25.56 | 2025 | Velys |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Essig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.